Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
HGH.AX
177.66%
▼ -8.62%
CIN.AX
7.54%
▲ 2.73%
Gross Margin
HGH.AX
47.45%
▼ -0.33%
CIN.AX
100.00%
Free Cash Flow
HGH.AX
-$45.81M
▼ -$11.31M
CIN.AX
$12.44M
▼ -$3.46M
Net Debt / EBITDA
HGH.AX
2.07
▲ 1.18
CIN.AX
-0.20
▲ 0.02
Operating Margin
HGH.AX
18.53%
▼ -1.46%
CIN.AX
98.03%
▲ 0.42%
P/E Ratio
HGH.AX
7.71
▼ -0.97
CIN.AX
12.16
▲ 0.45